Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT

NCT05288790 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.

NCT NCT05288790
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05288790 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
Lead sponsor
Vanderbilt University Medical Center
Phase
Phase 2
Overall status
Recruiting
Start date
September 18, 2023
Completion date
August 31, 2027
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol drinking, cardiovascular diseases, dysbiosis, hiv infections, microtia